L-Dopa and the treatment of extrapyramidal disease.

作者: Disease E. Williams Pelton , Thomas N. Chase

DOI: 10.1016/S1054-3589(08)60233-1

关键词: Phenylalanine hydroxylasePhenylalanineTyrosine hydroxylaseTyrosineAromatic L-amino acid decarboxylaseAmino acidHydroxylationBiochemistryTyrosinaseChemistry

摘要: Publisher Summary This chapter discusses the L-dopa and treatment of extrapyramidal disease. Although systemic administration elevates intraneuronal concentrations both dopa DA, dietary tyrosine serves as natural precursor these catechols in central nervous system. L-Tyrosine is hydroxylated meta-position to by hydroxylase. The enzyme requires molecular oxygen, ferrous iron, a reduced pteridine. It specific for hydroxylation L-tyrosine or L-phenylalanine, but ineffective D isomers m-tyzosine thus, differs from rather nonspecific phenol-oxidizing enzyme, tyrosinase. Tyrosine phenylalanine each inhibits hydroxylase other amino acid. Dopa decarboxylase that found soluble portion cell homogenates catalyzes conversion DA. pyridoxal phosphate-requiring has been thought act on all aromatic 1-amino acids including phenylalanine, tryptophan, 5-hydroxytryptophan, histidine. distribution ubiquitous outside within system, high gut mucosa walls brain capillaries.

参考文章(289)
E. Gr�ndig, F. Gerstenbrand, J. Oberhummer, M. Simanyi, R. Schedl, J. Weiss, Biochemische Aspekte der l-DOPA-Wirkung bei Parkinsonpatienten Zeitschrift f�r Neurologie. ,vol. 203, pp. 73- 90 ,(1972) , 10.1007/BF00316080
Sidney Udenfriend, Wallace Dairman, James G. Christenson, Changes in Tyrosine Hydroxylase and Dopa Decarboxylase Induced by Pharmacological Agents Pharmacological Reviews. ,vol. 24, pp. 269- 289 ,(1972)
Ulf Str�mberg, DOPA effects on motility in mice; potentiation by MK 485 and dexchlorpheniramine. Psychopharmacology. ,vol. 18, pp. 58- 67 ,(1970) , 10.1007/BF00402384
Ira B. Black, Julius Axelrod, Inhibition of tyrosine transaminase activity by norepinephrine. Journal of Biological Chemistry. ,vol. 244, pp. 6124- 6129 ,(1969) , 10.1016/S0021-9258(18)63514-8
A. Pletscher, G. Bartholini, Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase. Journal of Pharmacology and Experimental Therapeutics. ,vol. 161, pp. 14- 20 ,(1968)
J.A. Sharpe, N.B. Rewcastle, K.G. Lloyd, O. Hornykiewicz, M. Hill, R.R. Tasker, Striatonigral degeneration Journal of the Neurological Sciences. ,vol. 19, pp. 275- 286 ,(1973) , 10.1016/0022-510X(73)90091-9
Erminio Costa, Istituto di ricerche farmacologiche Mario Negri Related Compounds, Silvio Garattini, International Symposium on Amphetamines and Related Compounds Raven Press. ,(1970)